Concepts (172)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Nanoparticles | 11 | 2022 | 254 | 4.880 |
Why?
|
| Doxorubicin | 7 | 2018 | 231 | 2.150 |
Why?
|
| Drug Delivery Systems | 8 | 2022 | 236 | 2.120 |
Why?
|
| Antineoplastic Agents | 5 | 2020 | 1070 | 1.480 |
Why?
|
| Polymers | 5 | 2020 | 244 | 1.440 |
Why?
|
| Nanotechnology | 2 | 2020 | 109 | 1.250 |
Why?
|
| Gold | 2 | 2020 | 76 | 1.230 |
Why?
|
| Cell Line, Tumor | 13 | 2022 | 1851 | 1.030 |
Why?
|
| Head and Neck Neoplasms | 3 | 2019 | 561 | 0.930 |
Why?
|
| Polyethylene Glycols | 5 | 2017 | 149 | 0.870 |
Why?
|
| Polyethyleneimine | 2 | 2012 | 14 | 0.830 |
Why?
|
| Xenograft Model Antitumor Assays | 6 | 2020 | 304 | 0.800 |
Why?
|
| Oxidation-Reduction | 6 | 2020 | 567 | 0.780 |
Why?
|
| Phototherapy | 2 | 2020 | 28 | 0.760 |
Why?
|
| Melitten | 1 | 2020 | 2 | 0.740 |
Why?
|
| Curcumin | 1 | 2020 | 23 | 0.730 |
Why?
|
| Infrared Rays | 2 | 2017 | 12 | 0.720 |
Why?
|
| Chlorophyll | 1 | 2019 | 6 | 0.690 |
Why?
|
| Radiation-Sensitizing Agents | 1 | 2019 | 35 | 0.680 |
Why?
|
| Suramin | 1 | 2018 | 9 | 0.650 |
Why?
|
| Chitosan | 1 | 2018 | 11 | 0.650 |
Why?
|
| Brain Neoplasms | 1 | 2022 | 371 | 0.650 |
Why?
|
| Triple Negative Breast Neoplasms | 1 | 2018 | 41 | 0.630 |
Why?
|
| Drug Repositioning | 1 | 2017 | 8 | 0.610 |
Why?
|
| Disulfiram | 1 | 2017 | 22 | 0.610 |
Why?
|
| Colonic Neoplasms | 1 | 2020 | 299 | 0.610 |
Why?
|
| Polyglycolic Acid | 1 | 2017 | 20 | 0.590 |
Why?
|
| Breast Neoplasms | 5 | 2022 | 1536 | 0.580 |
Why?
|
| Nanospheres | 1 | 2017 | 8 | 0.570 |
Why?
|
| Receptor, ErbB-2 | 2 | 2016 | 129 | 0.570 |
Why?
|
| Pancreatic Neoplasms | 1 | 2020 | 332 | 0.570 |
Why?
|
| Hyperthermia, Induced | 1 | 2017 | 53 | 0.560 |
Why?
|
| Prodrugs | 1 | 2017 | 54 | 0.560 |
Why?
|
| Lactic Acid | 1 | 2017 | 86 | 0.560 |
Why?
|
| Silicon Dioxide | 1 | 2017 | 61 | 0.550 |
Why?
|
| Indoles | 1 | 2017 | 146 | 0.550 |
Why?
|
| Microglia | 1 | 2017 | 143 | 0.530 |
Why?
|
| Metal Nanoparticles | 1 | 2017 | 88 | 0.530 |
Why?
|
| Antigens, Differentiation | 1 | 2016 | 49 | 0.530 |
Why?
|
| Drug Resistance, Multiple | 1 | 2016 | 56 | 0.530 |
Why?
|
| Drug Resistance, Neoplasm | 3 | 2022 | 332 | 0.520 |
Why?
|
| Sulfhydryl Compounds | 1 | 2016 | 73 | 0.510 |
Why?
|
| HCT116 Cells | 4 | 2020 | 63 | 0.510 |
Why?
|
| Down-Regulation | 2 | 2016 | 447 | 0.500 |
Why?
|
| Organometallic Compounds | 1 | 2016 | 95 | 0.500 |
Why?
|
| Gels | 1 | 2014 | 55 | 0.480 |
Why?
|
| Photosensitizing Agents | 1 | 2014 | 32 | 0.480 |
Why?
|
| Mice | 9 | 2020 | 8474 | 0.480 |
Why?
|
| Copper | 1 | 2016 | 149 | 0.470 |
Why?
|
| Camptothecin | 1 | 2014 | 39 | 0.470 |
Why?
|
| Acetylcysteine | 1 | 2017 | 296 | 0.460 |
Why?
|
| Pyridines | 1 | 2016 | 261 | 0.460 |
Why?
|
| RNA-Binding Proteins | 1 | 2016 | 215 | 0.460 |
Why?
|
| Glutathione | 1 | 2016 | 343 | 0.460 |
Why?
|
| Lung Neoplasms | 2 | 2020 | 1173 | 0.440 |
Why?
|
| Up-Regulation | 1 | 2016 | 682 | 0.440 |
Why?
|
| Animals | 12 | 2020 | 20881 | 0.440 |
Why?
|
| Spermine | 1 | 2012 | 49 | 0.410 |
Why?
|
| Paclitaxel | 1 | 2012 | 140 | 0.400 |
Why?
|
| Mice, Nude | 4 | 2020 | 294 | 0.400 |
Why?
|
| Neurons | 1 | 2017 | 881 | 0.380 |
Why?
|
| Gene Transfer Techniques | 1 | 2012 | 173 | 0.380 |
Why?
|
| Genetic Vectors | 1 | 2012 | 312 | 0.380 |
Why?
|
| DNA | 2 | 2021 | 597 | 0.380 |
Why?
|
| Hyaluronic Acid | 1 | 2012 | 206 | 0.370 |
Why?
|
| MicroRNAs | 3 | 2022 | 447 | 0.350 |
Why?
|
| Particle Size | 3 | 2017 | 201 | 0.350 |
Why?
|
| Mitochondria | 1 | 2014 | 643 | 0.340 |
Why?
|
| Cell Proliferation | 4 | 2019 | 1174 | 0.340 |
Why?
|
| Ligands | 2 | 2020 | 317 | 0.330 |
Why?
|
| Drug Compounding | 2 | 2020 | 34 | 0.320 |
Why?
|
| Humans | 17 | 2022 | 68618 | 0.290 |
Why?
|
| ErbB Receptors | 2 | 2019 | 239 | 0.280 |
Why?
|
| Photochemotherapy | 2 | 2019 | 59 | 0.280 |
Why?
|
| Endocytosis | 2 | 2020 | 113 | 0.280 |
Why?
|
| Neoplasms | 1 | 2017 | 1667 | 0.270 |
Why?
|
| Temperature | 2 | 2020 | 341 | 0.270 |
Why?
|
| Tissue Distribution | 2 | 2017 | 282 | 0.260 |
Why?
|
| Cell Survival | 3 | 2019 | 901 | 0.250 |
Why?
|
| Kinetics | 2 | 2017 | 1047 | 0.230 |
Why?
|
| Transcytosis | 1 | 2022 | 1 | 0.220 |
Why?
|
| MCF-7 Cells | 2 | 2020 | 80 | 0.210 |
Why?
|
| Nanomedicine | 1 | 2022 | 19 | 0.210 |
Why?
|
| Blood-Brain Barrier | 1 | 2022 | 99 | 0.200 |
Why?
|
| Hydrogen-Ion Concentration | 2 | 2014 | 618 | 0.200 |
Why?
|
| Nanopores | 1 | 2021 | 4 | 0.190 |
Why?
|
| Asialoglycoprotein Receptor | 1 | 2020 | 11 | 0.190 |
Why?
|
| Erlotinib Hydrochloride | 1 | 2020 | 12 | 0.190 |
Why?
|
| Disaccharides | 1 | 2020 | 9 | 0.190 |
Why?
|
| Cell Line | 2 | 2017 | 1752 | 0.180 |
Why?
|
| Epoxy Compounds | 1 | 2020 | 20 | 0.180 |
Why?
|
| Biosensing Techniques | 1 | 2021 | 51 | 0.180 |
Why?
|
| Phenanthrenes | 1 | 2020 | 18 | 0.180 |
Why?
|
| Diterpenes | 1 | 2020 | 42 | 0.180 |
Why?
|
| Tumor Burden | 1 | 2020 | 132 | 0.180 |
Why?
|
| Antibodies, Viral | 1 | 2021 | 110 | 0.180 |
Why?
|
| Emodin | 1 | 2020 | 21 | 0.180 |
Why?
|
| Neoplastic Stem Cells | 1 | 2020 | 84 | 0.170 |
Why?
|
| HeLa Cells | 1 | 2019 | 237 | 0.170 |
Why?
|
| Human Umbilical Vein Endothelial Cells | 1 | 2018 | 45 | 0.160 |
Why?
|
| Hydrophobic and Hydrophilic Interactions | 1 | 2018 | 85 | 0.160 |
Why?
|
| Molecular Targeted Therapy | 1 | 2019 | 170 | 0.160 |
Why?
|
| Acrylates | 1 | 2017 | 17 | 0.150 |
Why?
|
| Proton Magnetic Resonance Spectroscopy | 1 | 2017 | 27 | 0.150 |
Why?
|
| Spheroids, Cellular | 1 | 2017 | 45 | 0.150 |
Why?
|
| Neoplasm Metastasis | 1 | 2018 | 306 | 0.150 |
Why?
|
| Drug Screening Assays, Antitumor | 2 | 2020 | 111 | 0.150 |
Why?
|
| Bivalvia | 1 | 2017 | 10 | 0.150 |
Why?
|
| Porosity | 1 | 2017 | 63 | 0.140 |
Why?
|
| Interleukin-1beta | 1 | 2017 | 88 | 0.140 |
Why?
|
| Protein Tyrosine Phosphatase, Non-Receptor Type 11 | 1 | 2016 | 19 | 0.140 |
Why?
|
| Feedback, Physiological | 1 | 2016 | 38 | 0.130 |
Why?
|
| Body Weight | 1 | 2017 | 554 | 0.130 |
Why?
|
| Female | 6 | 2022 | 38074 | 0.130 |
Why?
|
| Lipopolysaccharides | 1 | 2017 | 455 | 0.120 |
Why?
|
| Transfection | 2 | 2018 | 782 | 0.120 |
Why?
|
| MAP Kinase Signaling System | 1 | 2016 | 247 | 0.120 |
Why?
|
| Receptors, sigma | 1 | 2014 | 6 | 0.120 |
Why?
|
| Antioxidants | 1 | 2017 | 304 | 0.120 |
Why?
|
| Reactive Oxygen Species | 1 | 2017 | 499 | 0.120 |
Why?
|
| KB Cells | 1 | 2014 | 9 | 0.120 |
Why?
|
| Immunohistochemistry | 1 | 2017 | 1174 | 0.120 |
Why?
|
| Drug Carriers | 1 | 2014 | 90 | 0.110 |
Why?
|
| Microscopy, Confocal | 1 | 2014 | 337 | 0.110 |
Why?
|
| Oligopeptides | 1 | 2012 | 152 | 0.100 |
Why?
|
| Green Fluorescent Proteins | 1 | 2012 | 200 | 0.100 |
Why?
|
| Structure-Activity Relationship | 1 | 2012 | 420 | 0.100 |
Why?
|
| Surface Properties | 1 | 2012 | 363 | 0.100 |
Why?
|
| Molecular Structure | 1 | 2012 | 397 | 0.100 |
Why?
|
| Microscopy, Fluorescence | 1 | 2012 | 261 | 0.100 |
Why?
|
| Plasmids | 1 | 2012 | 258 | 0.100 |
Why?
|
| Magnetic Resonance Spectroscopy | 1 | 2012 | 346 | 0.090 |
Why?
|
| Gene Expression | 1 | 2012 | 770 | 0.080 |
Why?
|
| Dose-Response Relationship, Drug | 1 | 2012 | 1745 | 0.080 |
Why?
|
| Feedback | 1 | 2022 | 90 | 0.050 |
Why?
|
| Tamoxifen | 1 | 2022 | 62 | 0.050 |
Why?
|
| Signal Transduction | 2 | 2022 | 2689 | 0.050 |
Why?
|
| Estrogen Receptor alpha | 1 | 2022 | 65 | 0.050 |
Why?
|
| Antineoplastic Agents, Hormonal | 1 | 2022 | 99 | 0.050 |
Why?
|
| Estrogens | 1 | 2022 | 173 | 0.050 |
Why?
|
| Primary Cell Culture | 1 | 2020 | 56 | 0.040 |
Why?
|
| Immunoglobulin M | 1 | 2021 | 172 | 0.040 |
Why?
|
| Coculture Techniques | 1 | 2020 | 147 | 0.040 |
Why?
|
| Mastectomy | 1 | 2020 | 57 | 0.040 |
Why?
|
| Chemotherapy, Adjuvant | 1 | 2020 | 129 | 0.040 |
Why?
|
| Cell Communication | 1 | 2020 | 116 | 0.040 |
Why?
|
| Mammary Neoplasms, Experimental | 1 | 2020 | 114 | 0.040 |
Why?
|
| Enzyme-Linked Immunosorbent Assay | 1 | 2021 | 507 | 0.040 |
Why?
|
| Transforming Growth Factor beta1 | 1 | 2020 | 126 | 0.040 |
Why?
|
| Neoplasm Recurrence, Local | 1 | 2022 | 446 | 0.040 |
Why?
|
| Epithelial-Mesenchymal Transition | 1 | 2020 | 135 | 0.040 |
Why?
|
| Tumor Microenvironment | 1 | 2020 | 213 | 0.040 |
Why?
|
| Computational Biology | 1 | 2020 | 190 | 0.040 |
Why?
|
| Autophagy-Related Protein-1 Homolog | 1 | 2018 | 1 | 0.040 |
Why?
|
| Immunoglobulin G | 1 | 2021 | 481 | 0.040 |
Why?
|
| Oncogene Proteins | 1 | 2018 | 35 | 0.040 |
Why?
|
| Microarray Analysis | 1 | 2018 | 63 | 0.040 |
Why?
|
| Gene Expression Regulation, Neoplastic | 1 | 2022 | 756 | 0.040 |
Why?
|
| Cell Movement | 1 | 2020 | 630 | 0.040 |
Why?
|
| Intracellular Signaling Peptides and Proteins | 1 | 2018 | 216 | 0.040 |
Why?
|
| Random Allocation | 1 | 2018 | 442 | 0.040 |
Why?
|
| Sensitivity and Specificity | 1 | 2021 | 1753 | 0.030 |
Why?
|
| Genetic Therapy | 1 | 2018 | 291 | 0.030 |
Why?
|
| Autophagy | 1 | 2018 | 208 | 0.030 |
Why?
|
| Transplantation, Heterologous | 1 | 2016 | 122 | 0.030 |
Why?
|
| Neoplasm Transplantation | 1 | 2016 | 160 | 0.030 |
Why?
|
| In Situ Hybridization, Fluorescence | 1 | 2016 | 144 | 0.030 |
Why?
|
| Real-Time Polymerase Chain Reaction | 1 | 2016 | 209 | 0.030 |
Why?
|
| Breast | 1 | 2016 | 137 | 0.030 |
Why?
|
| HEK293 Cells | 1 | 2016 | 326 | 0.030 |
Why?
|
| Membrane Proteins | 1 | 2018 | 617 | 0.030 |
Why?
|
| Male | 1 | 2014 | 37321 | 0.030 |
Why?
|